Literature DB >> 19520616

T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus.

Ying Zhou1, Jun Yuan, Yujun Pan, Yiping Fei, Xiangning Qiu, Nan Hu, Yongqi Luo, Wenzhi Lei, Yaping Li, Hai Long, Amr H Sawalha, Bruce Richardson, Qianjin Lu.   

Abstract

CD40 ligand (CD40LG), encoded on the X chromosome, has been reported to be overexpressed on lupus T cells. Herein, we investigated the effect of DNA demethylation on T cell CD40LG expression and the production of IgG by autologous B cells in lupus. We found normal human T cells transfected with CD40LG induced autologous B cell activation and plasma cell differentiation. Both female lupus CD4+ T cells and demethylating agents treated CD4+ T cells overexpressed CD40LG mRNA. Further, lupus T cells from both genders or demethylated CD4+ T cells from healthy women overstimulated autologous B cells, and this could be reversed with anti-CD40LG Ab in only females. We demonstrated that female lupus CD4+ T cells and demethylated CD4+ T cells express high level of CD40LG and overstimulate B cells to produce IgG. This is due to DNA demethylation and thereby reactivation of the inactive X chromosome in female.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520616      PMCID: PMC2810511          DOI: 10.1016/j.clim.2009.05.011

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  33 in total

1.  The role of CD40-CD154 interactions in the regulation of cell mediated immunity.

Authors:  A Miga; S Masters; M Gonzalez; R J Noelle
Journal:  Immunol Invest       Date:  2000-05       Impact factor: 3.657

2.  Epigenetic aspects of X-chromosome dosage compensation.

Authors:  Y Park; M I Kuroda
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

Review 3.  Genomic patterns of DNA methylation: targets and function of an epigenetic mark.

Authors:  Michael Weber; Dirk Schübeler
Journal:  Curr Opin Cell Biol       Date:  2007-04-26       Impact factor: 8.382

Review 4.  Sex ratio and rheumatic disease: excerpts from an Institute of Medicine report.

Authors:  M D Lockshin
Journal:  Lupus       Date:  2002       Impact factor: 2.911

Review 5.  Co-stimulatory blockade in the treatment of murine systemic lupus erythematosus (SLE).

Authors:  Anne Davidson; Xiaobo Wang; Masahiko Mihara; Meera Ramanujam; Weiqing Huang; Lena Schiffer; Jayashree Sinha
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

Review 6.  DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.

Authors:  Ying Zhou; Qianjin Lu
Journal:  Autoimmun Rev       Date:  2008-04-04       Impact factor: 9.754

7.  Demethylation of CD40LG on the inactive X in T cells from women with lupus.

Authors:  Qianjin Lu; Ailing Wu; Laura Tesmer; Donna Ray; Neda Yousif; Bruce Richardson
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

8.  Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus.

Authors:  Qianjin Lu; Mariana Kaplan; Donna Ray; Doreen Ray; Sima Zacharek; David Gutsch; Bruce Richardson
Journal:  Arthritis Rheum       Date:  2002-05

9.  Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.

Authors:  E Cornacchia; J Golbus; J Maybaum; J Strahler; S Hanash; B Richardson
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

10.  Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling.

Authors:  Chun Deng; Qianjin Lu; Zhiyong Zhang; Tharaknath Rao; John Attwood; Raymond Yung; Bruce Richardson
Journal:  Arthritis Rheum       Date:  2003-03
View more
  39 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus.

Authors:  Faith M Strickland; Anura Hewagama; Qianjian Lu; Ailing Wu; Robert Hinderer; Ryan Webb; Kent Johnson; Amr H Sawalha; Colin Delaney; Raymond Yung; Bruce C Richardson
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

3.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 4.  Orthopedic surgery and its complication in systemic lupus erythematosus.

Authors:  Anselm Mak
Journal:  World J Orthop       Date:  2014-01-18

5.  Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.

Authors:  M H Napimoga; E P Rocha; C A Trindade-da-Silva; A P D Demasi; E F Martinez; C G Macedo; H B Abdalla; A Bettaieb; F G Haj; J T Clemente-Napimoga; B Inceoglu; B D Hammock
Journal:  J Periodontal Res       Date:  2018-05-31       Impact factor: 4.419

Review 6.  Review of the "X chromosome-nucleolus nexus" hypothesis of autoimmune diseases with an update explaining disruption of the nucleolus.

Authors:  Wesley H Brooks
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

7.  Accelerated atherosclerosis in SLE: mechanisms and prevention approaches.

Authors:  Ashley J Wilhelm; Amy S Major
Journal:  Int J Clin Rheumtol       Date:  2012-10-01

8.  Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus.

Authors:  Katsue Sunahori; Yuang-Taung Juang; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

Review 9.  DNA methylation alterations in the pathogenesis of lupus.

Authors:  S H Chen; Q L Lv; L Hu; M J Peng; G H Wang; B Sun
Journal:  Clin Exp Immunol       Date:  2016-11-01       Impact factor: 4.330

Review 10.  [Sex-specific differences of the immune system].

Authors:  G Riemekasten; E Siegert
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.